Remixpoint, Inc. provided consolidated earnings guidance for the fiscal year ending March 31, 2023. For the year, the company expects net sales of JPY 31,966 million, operating loss of JPY 1,899 million, profit attributable to owners of parent of JPY 3,301 million and basic earnings per share of JPY 27.61.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
167 JPY | +3.73% | +5.03% | -12.11% |
Feb. 14 | Remixpoint, Inc. Omits to Pay Year End Dividend for the Year Ending March 31, 2024 | CI |
2023 | Remixpoint, Inc. completed the acquisition of Zero Medical.Inc. from Yukihiro Hara. | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.11% | 124M | |
+25.72% | 156B | |
+14.09% | 86.59B | |
+3.71% | 83.95B | |
+7.27% | 80B | |
+0.07% | 74.58B | |
+88.72% | 67.8B | |
+14.36% | 48.81B | |
+14.35% | 45.08B | |
0.00% | 44.11B |
- Stock Market
- Equities
- 3825 Stock
- News Remixpoint, Inc.
- Remixpoint, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023